International variations in infection supportive care practices for paediatric patients with acute myeloid leukaemia

British Journal of Haematology

Volumn 147, Issue 1, 2009, Pages 125-128

  Lehrnbecher, Thomas ^a   Ethier, Marie Chantal ^b   Zaoutis, Theoklis ^c   Creutzig, Ursula ^d   Gamis, Alan ^e   Reinhardt, Dirk ^f   Aplenc, Richard ^c   Sung, Lillian ^b  

^a GOETHE UNIVERSITY   (Germany)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d UNIVERSITY OF MÜNSTER   (Germany)

^e CHILDREN S MERCY HOSPITAL   (United States)

^f HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Acute myeloid leukaemia; Children; Fungal; Infection; Prophylaxis

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CIPROFLOXACIN; FLUCONAZOLE; PENICILLIN G; POSACONAZOLE; VANCOMYCIN; VORICONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; CHILD CARE; CHILDHOOD LEUKEMIA; CLINICAL PRACTICE; CONTROLLED STUDY; FEBRILE NEUTROPENIA; GRAM POSITIVE INFECTION; HEALTH SURVEY; HUMAN; MYCOSIS; PRIORITY JOURNAL;

ANTIBIOTIC PROPHYLAXIS; ANTIFUNGAL AGENTS; BACTERIAL INFECTIONS; DRUG UTILIZATION; HEALTH CARE SURVEYS; HUMANS; INTERNATIONAL COOPERATION; LEUKEMIA, MYELOID, ACUTE; MYCOSES; OPPORTUNISTIC INFECTIONS; PROFESSIONAL PRACTICE;

EID: 70349202107     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07844.x     Document Type: Article

References (9)

1. Boragina, M., Patel, H., Reiter, S. Dougherty, G. (2007) Management of febrile neutropenia in pediatric oncology patients: a Canadian survey. Pediatric Blood & Cancer, 48, 521 526.
2. Harbarth, S., Viot, M., Beeler, I., Klastersky, J. Szucs, T. (2000) Variation in antimicrobial utilization for febrile neutropenia in cancer patients. The CEMIC Study Group. Club d'Etudes des Maladies Infectieuses en Cancer. Infection, 28, 375 378.
3. Lehrnbecher, T., Varwig, D., Kaiser, J., Reinhardt, D., Klingebiel, T. Creutzig, U. (2004) Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93. Leukemia, 18, 72 77.
4. Redaelli, A., Botteman, M.F., Stephens, J.M., Brandt, S. Pashos, C.L. (2004) Economic burden of acute myeloid leukemia: a literature review. Cancer Treatment Reviews, 30, 237 247.
5. Riley, L.C., Hann, I.M., Wheatley, K. Stevens, R.F. (1999) Treatment-related deaths during induction and first remission of acute myeloid leukaemia in children treated on the Tenth Medical Research Council acute myeloid leukaemia trial (MRC AML10). The MRC Childhood Leukaemia Working Party. British Journal of Haematology, 106, 436 444.
6. Sung, L., Lange, B.J., Gerbing, R.B., Alonzo, T.A. Feusner, J. (2007) Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia. Blood, 110, 3532 3539.
7. Sung, L., Aplenc, R., Zaoutis, T., Groll, A.H., Gibson, B. Lehrnbecher, T. (2008) Infections in pediatric acute myeloid leukemia: lessons learned and unresolved questions. Pediatric Blood & Cancer, 51, 458 460.
8. Ziglam, H.M., Gelly, K.J. Olver, W.J. (2005) A survey of the antibiotic treatment of febrile neutropenia in haematology units in the United Kingdom. Clinical and Laboratory Haematology, 27, 374 378.
9. Ziglam, H.M., Gelly, K. Olver, W. (2007) A survey of the management of neutropenic fever in oncology units in the UK. International Journal of Antimicrobial Agents, 29, 430 433.